id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0429-0002,FDA,FDA-2010-N-0429,Immunology and Microbiology Devices: Reclassification of the Herpes Simplex Virus Serological Assay Device,Rule,Final Rule,2011-08-09T04:00:00Z,2011,8,2011-08-09T04:00:00Z,,2012-03-24T19:30:33Z,2011-20115,0,0,0900006480edbab0
FDA-2010-N-0429-0001,FDA,FDA-2010-N-0429,Immunology and Microbiology Devices: Reclassification of Herpes Simplex Virus Serological Assay Device,Proposed Rule,NPR-Notice of Proposed Rule-Making,2010-09-28T04:00:00Z,2010,9,2010-09-28T04:00:00Z,2010-11-30T04:59:59Z,2024-11-12T04:55:04Z,2010-23639,1,0,0900006480b6227c